Skip to main content
. 2011 Sep 27;3(4):3714–3725. doi: 10.3390/cancers3043714

Figure 2.

Figure 2.

Expression of HOXC6 target genes in prostate cancer. (A) Expression of CNTN1 mRNA as measured by quantitative RT-PCR in 45 prostate carcinoma and 13 benign prostate tissues; (B) Expression of DKK3 mRNA in the same set of tissues; (C) Expression of WIF1 mRNA in the same set of tissues; (D–F) Plots of CNTN1, DKK3 and WIF1 expression against HOXC6 expression. In each case, there was a highly significant (p < 0.001) inverse correlation.